MedTrace Logo

The VIS Opti-K Low Vision Aid Device Provides Vision Improvement.

NCT06597292 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2024-09-25

No results posted yet for this study

Summary

The VIS Opti-K Low Vision Aid device will be used to provide vision improvement to patients with refractive disorders (hyperopia and presbyopia).

Conditions

Interventions

DEVICE

Vision improvement

Vision improvement for patients with refractive disorders (hyperopia and presbyopia)

Sponsors & Collaborators

  • VIS, Inc.

    lead INDUSTRY

Principal Investigators

  • Michael Berry, PhD · VIS, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-16
Primary Completion
2026-09-30
Completion
2026-12-30
FDA Device
Yes

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06597292 on ClinicalTrials.gov